Stryker Corporation (SYK) Shares Sold by American International Group Inc.

American International Group Inc. trimmed its stake in Stryker Corporation (NYSE:SYK) by 1.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 140,411 shares of the medical technology company’s stock after selling 1,641 shares during the quarter. American International Group Inc.’s holdings in Stryker Corporation were worth $19,941,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Acrospire Investment Management LLC purchased a new stake in shares of Stryker Corporation in the second quarter worth approximately $111,000. Motco lifted its position in shares of Stryker Corporation by 50.7% in the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 278 shares in the last quarter. Bollard Group LLC lifted its position in shares of Stryker Corporation by 0.4% in the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 3 shares in the last quarter. Bruderman Asset Management LLC purchased a new stake in shares of Stryker Corporation in the second quarter worth approximately $150,000. Finally, James Investment Research Inc. bought a new position in Stryker Corporation during the second quarter valued at approximately $155,000. 74.20% of the stock is owned by institutional investors and hedge funds.

Shares of Stryker Corporation (NYSE SYK) traded down $0.94 during trading on Friday, hitting $154.79. 874,300 shares of the stock traded hands, compared to its average volume of 1,175,304. The firm has a market capitalization of $57,928.24, a P/E ratio of 24.53, a price-to-earnings-growth ratio of 2.44 and a beta of 0.79. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. Stryker Corporation has a twelve month low of $110.00 and a twelve month high of $160.62.

Stryker Corporation (NYSE:SYK) last announced its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.02. The business had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.97 billion. Stryker Corporation had a net margin of 14.67% and a return on equity of 24.11%. Stryker Corporation’s quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the company posted $1.39 earnings per share. analysts anticipate that Stryker Corporation will post 6.47 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Stryker Corporation (SYK) Shares Sold by American International Group Inc.” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://sportsperspectives.com/2017/11/24/stryker-corporation-syk-shares-sold-by-american-international-group-inc.html.

In other news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the sale, the insider now owns 83,207 shares in the company, valued at $12,925,375.38. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 7.40% of the company’s stock.

Several brokerages recently weighed in on SYK. Cowen Inc set a $166.00 price objective on shares of Stryker Corporation and gave the company a “buy” rating in a research report on Sunday, October 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker Corporation in a research report on Friday, November 3rd. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $161.00 price objective on shares of Stryker Corporation in a research report on Friday, November 17th. Oppenheimer Holdings, Inc. set a $156.00 price objective on shares of Stryker Corporation and gave the company a “hold” rating in a research report on Monday, October 30th. Finally, Robert W. Baird raised shares of Stryker Corporation from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $161.00 to $173.00 in a research report on Thursday, November 16th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and fourteen have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $152.10.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply